Home
Resources
Publications
2-(4-(Biphenyl-4-ylamino)-6-chloropyrimidin-2-ylthio)octanoic Acid (HZ52)--a Novel Type of 5-lipoxygenase Inhibitor With Favourable Molecular Pharmacology and Efficacy in Vivo

2-(4-(Biphenyl-4-ylamino)-6-chloropyrimidin-2-ylthio)octanoic Acid (HZ52)--a Novel Type of 5-lipoxygenase Inhibitor With Favourable Molecular Pharmacology and Efficacy in Vivo

C Greiner, C Hörnig, A Rossi, C Pergola, H Zettl, M Schubert-Zsilavecz, D Steinhilber, L Sautebin, O Werz

Br J Pharmacol. 2011 Sep;164(2b):781-93.

PMID: 21506958

Abstract:

Background and purpose:
5-Lipoxygenase (5-LO) is the key enzyme in the biosynthesis of pro-inflammatory leukotrienes (LTs) representing a potential target for pharmacological intervention with inflammation and allergic disorders. Although many LT synthesis inhibitors are effective in simple in vitro test systems, they frequently fail in vivo due to lack of efficacy. Here, we attempted to assess the pharmacological potential of the previously identified 5-LO inhibitor 2-(4-(biphenyl-4-ylamino)-6-chloropyrimidin-2-ylthio)octanoic acid (HZ52).
Experimental approach:
We evaluated the efficacy of HZ52 in vivo using carrageenan-induced pleurisy in rats and platelet-activating factor (PAF)-induced lethal shock in mice. We also characterized 5-LO inhibition by HZ52 at the cellular and molecular level in comparison with other types of 5-LO inhibitor, that is, BWA4C, ZM230487 and hyperforin.
Key results:
HZ52, 1.5 mg·kg⁻¹ i.p., prevented carrageenan-induced pleurisy accompanied by reduced LTB(4) levels and protected mice (10 mg·kg⁻¹, i.p.) against PAF-induced shock. Detailed analysis in cell-based and cell-free assays revealed that inhibition of 5-LO by HZ52 (i) does not depend on radical scavenging properties and is reversible; (ii) is not impaired by an increased peroxide tone or by elevated substrate concentrations; and (iii) is little affected by the cell stimulus or by phospholipids, glycerides, membranes or Ca²⁺.
Conclusions and implications:
HZ52 is a promising new type of 5-LO inhibitor with efficacy in vivo and with a favourable pharmacological profile. It possesses a unique 5-LO inhibitory mechanism different from classical 5-LO inhibitors and seemingly lacks the typical disadvantages of former classes of LT synthesis blockers.

Chemicals Related in the Paper:

Catalog Number	Product Name	Structure	CAS Number	Price
AP1077626517	HZ52		1077626-51-7	Price

As a specialist in analytical chemical Products, Alfa Chemistry offers consumers a wealth of raw materials and a full range of technologies and services.

QUICK LINKS

HEADQUARTERS

Tel:

Fax:

Email: